Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Adam David Sachs, CEO of Vicarious Surgical Inc. (NYSE:RBOT), recently sold 535 shares of the company’s Class A common stock. The shares were sold at a weighted average price of $10.28, amounting to a total transaction value of approximately $5,499. The stock has seen significant volatility, dropping 25% in the past week despite gaining over 54% in the last six months. This transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units granted on June 2, 2023. Following the sale, Sachs holds 52,164 shares directly. The sales were conducted with prices ranging from $9.40 to $11.00 per share. According to InvestingPro analysis, the company maintains a strong liquidity position with a current ratio of 7.44 and holds more cash than debt on its balance sheet. Investors can access 12 additional ProTips and comprehensive analysis through InvestingPro’s detailed research report.
In other recent news, Vicarious Surgical Inc. announced that its Chief Operating Officer, John Mazzola, will retire on April 1, 2025, after nearly four decades in the healthcare sector. Randy Clark, the company’s current President, will assume Mazzola’s duties upon his retirement. Additionally, Vicarious Surgical has entered into a consulting agreement with its former Chief Financial Officer, William Kelly. Under this agreement, Kelly will provide advisory services from January 2, 2025, through December 31, 2028. For the first six months, he will receive a monthly compensation of $10,000, after which he will be paid an hourly rate. Kelly will also retain vesting rights to his stock options and restricted stock units until June 30, 2025. These developments are part of Vicarious Surgical’s ongoing strategic initiatives as it continues to innovate in the medical device sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.